ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm
On May 26, 2023, ADDvise Group AB (publ) (“ADDvise”) successfully issued senior secured bonds in an initial amount of SEK 1,000 million, under a total framework of SEK 2,000 million (the “Bonds”).
Pursuant to the terms and conditions for the Bonds, ADDvise has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For this purpose, the company has prepared a listing prospectus, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available at the company’s website www.addvisegroup.com and at the Swedish Financial Supervisory Authority’s website www.fi.se. The application for admission to trading has been submitted and the first day of trading of the Bonds is estimated to be around June 28, 2023.
For further information, please contact:
Hanna Myhrman, General Counsel
+46 709 82 92 23
About ADDvise Group AB (publ)
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.